Rheonix Revenue and Competitors

Ithaca, NY USA

Location

$86.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rheonix's estimated annual revenue is currently $16.1M per year.(i)
  • Rheonix's estimated revenue per employee is $194,217
  • Rheonix's total funding is $86.7M.

Employee Data

  • Rheonix has 83 Employees.(i)
  • Rheonix grew their employee count by -15% last year.

Rheonix's People

NameTitleEmail/Phone
1
President, CEO and ChairmanReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
VP Strategy and MarketingReveal Email/Phone
4
VP QualityReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Director, Technology Transfer and Quality ControlReveal Email/Phone
7
Director Laboratory ServicesReveal Email/Phone
8
Director Human ResourcesReveal Email/Phone
9
Project ManagerReveal Email/Phone
10
Senior Manufacturing Process EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M40%N/AN/A
#2
$3.7M2441%$44MN/A
#3
$6.2M40-7%N/AN/A
#4
$42M271-1%N/AN/A
#5
$12.7M820%$10MN/A
#6
$2.5M160%N/AN/A
#7
$7.5M450%$51.6MN/A
#8
$0.2M1-50%N/AN/A
#9
$4.3M26-16%$3.3MN/A
#10
$3.7M244%N/AN/A
Add Company

What Is Rheonix?

Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few.

keywords:N/A

$86.7M

Total Funding

83

Number of Employees

$16.1M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Rheonix News

2022-04-06 - Handheld SARS-CoV-2 Saliva Test Earns CE Mark | AACC.org

Rheonix will also seek FDA approval for additional syndromic diagnostic panels that leverage the Encompass MDx workstation's ability to perform...

2010-04-21 - Rheonix Completes $12.6M Series A financing

Rheonix, Inc., an Ithaca, NY-based developer of a polymer chip microfluidic technology for the molecular diagnostics industry, completed a $12.6m Series A financing. The funding was provided by a syndicate of regional and international firms, which was led by the Cayuga Venture Fund and Bill an ...

2009-11-06 - Rheonix Secures $250,000 Equity Funding

Rheonix, Inc., a Ithaca, New York-based spin out of the microfluidic division of Kionix, Inc., secured a $250,000 equity funding from Rand Capital Corporation (Nasdaq:RAND), a business development company that provides capital and managerial expertise for small to medium-sized private companies. ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.3M8510%N/A
#2
$17.4M86-22%$35M
#3
$15.8M8835%N/A
#4
$20.5M9020%N/A
#5
$25.1M9327%N/A